Biotech

Category / Pharmaceuticals & Biotech / Biotech

ProMetic Progresses Into a Licensing and Long-Term Supply Agreement With an Existing Multinational Client

LAVAL, QUEBEC: - ProMetic's latest commercial application of its affinity resin technology key to enabling an improved next-generation biopharmaceutical product - Agreement follows successful development and sc ...

DBV Technologies Completes Enrollment of Phase IIb VIPES Study, the First-Ever Global Trial in Desensitization to Peanut Allergy

BAGNEUX, FRANCE: ...

Paladin Labs Inc. and Bioniche Life Sciences Inc. Officially Close Debt Refinancing and Urocidin(TM) Licensing Deals

MONTREAL, QUEBEC: ...

Biosenta Rushes ZeroMold Products to Support Flooded Calgary Community

TORONTO, ONTARIO: ...

Prima BioMed Activates Study Sites in Germany and Multiple European Countries for "CANVAS" Clinical Trial

SYDNEY, AUSTRALIA: ...

Ceapro Announces Re-Election of Board Members at its Annual Meeting of Shareholders

EDMONTON, ALBERTA: ...

Sarepta Therapeutics Announces At-the-Market Equity Offering Facility

CAMBRIDGE, MA: ...

Theratechnologies to Announce Second Quarter 2013 Financial Results

MONTREAL, QUEBEC: ...

IBEX Grant of Options

MONTREAL, QUEBEC: ...

Peregrine to Report Fourth Quarter and Year-End Fiscal Year 2013 Financial Results After Market Close on July 11, 2013

TUSTIN, CA: ...

Thallion's Annual and Special Meeting to Be Held August 6, 2013

MONTREAL, QUEBEC: Shareholders to Vote on Acquisition by BELLUS ...

HTG Launches Two Multiplexed Gene Expression Assays for Use on Award-Winning HTG Edge System

TUCSON, AZ: ...

Dynavax to Present at the JMP Securities Healthcare Conference

BERKELEY, CA: ...

Miraculins Executes Final Agreement for Acquisition of VeraLight's SCOUT DS(R) Non-Invasive Diabetes Screening Technology

WINNIPEG, MANITOBA: Test to Assist in Global Screening of World's Fastest Growing Disease ...

Insys Therapeutics to Present at the 2013 JMP Securities Healthcare Conference

PHOENIX, AZ: ...

Aeolus' AEOL 10150 Significantly Improves Survival From Nitrogen Mustard Exposure to Skin in Animals

MISSION VIEJO, CA: ...

Paladin Labs Acquires Binotal(R) in Latin America From Bayer

MONTREAL, CANADA: ...

Portola Announces Positive Phase 2 Study Results Showing Factor Xa Inhibitor Antidote PRT4445 Reverses Anticoagulant Activity of Eliquis(R)

AMSTERDAM, THE NETHERLANDS and SOUTH SAN FRANCISCO, CA: Data Presented in Oral Session at 2013 Congress of the International Society on Thrombosis and Haemostasis ...

Horizon Pharma to Present at the 8th Annual JMP Securities Healthcare Conference

DEERFIELD, IL: ...

Threshold Pharmaceuticals Announces Presentation and Webcast at the JMP Securities Healthcare Conference

SOUTH SAN FRANCISCO, CA: ...

Page 129 von 247: 1 « .. 128 129 130 131 132 133 134 135 136 137 .. » 247

All members:	10 565
Register today:	0
Register yesterday:	0
Members online:	0
Guests online:	115

Biotech

Category / Pharmaceuticals & Biotech / Biotech

ProMetic Progresses Into a Licensing and Long-Term Supply Agreement With an Existing Multinational Client

DBV Technologies Completes Enrollment of Phase IIb VIPES Study, the First-Ever Global Trial in Desensitization to Peanut Allergy

Paladin Labs Inc. and Bioniche Life Sciences Inc. Officially Close Debt Refinancing and Urocidin(TM) Licensing Deals

Biosenta Rushes ZeroMold Products to Support Flooded Calgary Community

Prima BioMed Activates Study Sites in Germany and Multiple European Countries for "CANVAS" Clinical Trial

Ceapro Announces Re-Election of Board Members at its Annual Meeting of Shareholders

Sarepta Therapeutics Announces At-the-Market Equity Offering Facility

Theratechnologies to Announce Second Quarter 2013 Financial Results

IBEX Grant of Options

Peregrine to Report Fourth Quarter and Year-End Fiscal Year 2013 Financial Results After Market Close on July 11, 2013

Thallion's Annual and Special Meeting to Be Held August 6, 2013

HTG Launches Two Multiplexed Gene Expression Assays for Use on Award-Winning HTG Edge System

Dynavax to Present at the JMP Securities Healthcare Conference

Miraculins Executes Final Agreement for Acquisition of VeraLight's SCOUT DS(R) Non-Invasive Diabetes Screening Technology

Insys Therapeutics to Present at the 2013 JMP Securities Healthcare Conference

Aeolus' AEOL 10150 Significantly Improves Survival From Nitrogen Mustard Exposure to Skin in Animals

Paladin Labs Acquires Binotal(R) in Latin America From Bayer

Portola Announces Positive Phase 2 Study Results Showing Factor Xa Inhibitor Antidote PRT4445 Reverses Anticoagulant Activity of Eliquis(R)

Horizon Pharma to Present at the 8th Annual JMP Securities Healthcare Conference

Threshold Pharmaceuticals Announces Presentation and Webcast at the JMP Securities Healthcare Conference

Service Menu

New here

Who is online